Casdin Capital’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Hold |
86,014
| – | – | 0.04% | 32 |
|
|
2025
Q1 | $399K | Hold |
86,014
| – | – | 0.03% | 41 |
|
|
2024
Q4 | $597K | Hold |
86,014
| – | – | 0.04% | 36 |
|
|
2024
Q3 | $456K | Sell |
86,014
-175,000
| -67% | -$928K | 0.03% | 33 |
|
|
2024
Q2 | $976K | Sell |
261,014
-249,868
| -49% | -$935K | 0.07% | 35 |
|
|
2024
Q1 | $3.6M | Hold |
510,882
| – | – | 0.27% | 30 |
|
|
2023
Q4 | $2.89M | Hold |
510,882
| – | – | 0.28% | 31 |
|
|
2023
Q3 | $2.45M | Hold |
510,882
| – | – | 0.27% | 32 |
|
|
2023
Q2 | $3.5M | Hold |
510,882
| – | – | 0.31% | 32 |
|
|
2023
Q1 | $3.98M | Hold |
510,882
| – | – | 0.33% | 34 |
|
|
2022
Q4 | $3.89M | Hold |
510,882
| – | – | 0.3% | 38 |
|
|
2022
Q3 | $4.17M | Hold |
510,882
| – | – | 0.27% | 28 |
|
|
2022
Q2 | $4.94M | Sell |
510,882
-450,000
| -47% | -$4.35M | 0.42% | 29 |
|
|
2022
Q1 | $13.5M | Hold |
960,882
| – | – | 0.6% | 31 |
|
|
2021
Q4 | $19.6M | Sell |
960,882
-1
| -0% | -$20 | 0.55% | 36 |
|
|
2021
Q3 | $21.4M | Hold |
960,883
| – | – | 0.53% | 38 |
|
|
2021
Q2 | $21.8M | Buy |
+960,883
| New | +$21.8M | 0.55% | 35 |
|